 Sana Biotechnology Inc. SANA , Financial and Lyel Immunopharma Inc. LYEL , Financial are poster children for whats happening in the biotech initial public offering market. The two companies raised a combined total of 1 billion in 2021 and at one point had valuations exceeding a combined 5 billion. 